מתחמי מטופלים
מתחמי קהל רחב
References
[1]
TECVAYLI® patient information leaflet approved by the Israeli MOH
[2]
Shimabukuro-Vornhagen A et al. J Immunother Cancer 2018; 6(1):56.
[3]
Lee DW et al. Blood 2014; 124(2):188–1953
[4]
Rasche L et al. Haematologica 2021; 106(10):2555–2565
[5]
TECVAYLI® prescribing information (Pl} approved by the Israeli MOH
